Antidiabetic and antioxidative effect of Jiang Tang Xiao Ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Zhao, Dan Dan ^a   Yu, Na ^a   Li, Xiao Ke ^a   Fang, Xin ^a   Mu, Qian Qian ^a   Qin, Pei Jie ^a   Ma, Yue ^a   Mo, Fang Fang ^a   Zhang, Dong Wei ^a   Gao, Si Hua ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; CHOLESTEROL; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; JIANG TANG XIAO KE GRANULE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; PIOGLITAZONE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPTIS; ENZYME ACTIVITY; ENZYME REPRESSION; FRUIT; GINSENG; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; RAT; REHMANNIA; SALVIA MILTIORRHIZA; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84904119941     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/475192     Document Type: Article

References (35)

1. Chen L., Magliano D. J., Zimmet P. Z., The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nature Reviews Endocrinology 2012 8 4 228 236 2-s2.0-84858702540 10.1038/nrendo.2011.183
2. Rhodes E. T., Prosser L. A., Hoerger T. J., Lieu T., Ludwig D. S., Laffel L. M., Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabetic Medicine 2012 29 4 453 463 2-s2.0-84858252996 10.1111/j.1464-5491.2011.03542.x
3. Rotella C. M., Pala L., Mannucci E., Role of insulin in the type 2 diabetes therapy: past, present and future. International Journal of Endocrinology and Metabolism 2013 11 3 137 144
4. Fonseca V. A., New developments in diabetes management: medications of the 21st century. Clinical Therapeutics 2014 36 4 477 484 10.1016/j.clinthera. 2014.01.018
5. Gomez-Peralta F., Abreu P. C., Do we need new treatments for type 2 diabetes? Endocrinología y Nutrición 2014 10.1016/j.endonu.2013. 10.013
6. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 2-s2.0-84861081399 10.1155/2012/268542 268542
7. Wu L., Li X., Zhu H., Xu P., Gao X., A prescribed Chinese herbal medicine improves glucose profile and ameliorates oxidative stress in Goto-Kakisaki rats fed with high fat diet. PLoS ONE 2013 8 4 2-s2.0-84875680119 10.1371/journal.pone.0060262 e60262
8. Patel D. K., Prasad S. K., Kumar R., Hemalatha S., An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pacific Journal of Tropical Biomedicine 2012 2 4 320 330 2-s2.0-84863393217 10.1016/S2221-1691(12)60032-X
9. Zhang T. T., Jiang J. G., Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opinion on Investigational Drugs 2012 21 11 1625 1642 2-s2.0-84867506579 10.1517/13543784.2012.713937
10. Folli F., Corradi D., Fanti P., Davalli A., Paez A., Giaccari A., Perego C., Muscogiuri G., The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Current Diabetes Reviews 2011 7 5 313 324 2-s2.0-80053515769
11. Akash M. S. H., Rehman K., Chen S., Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry 2013 114 3 525 531 2-s2.0-84872772714 10.1002/jcb.24402
12. Matough F. A., Budin S. B., Hamid Z. A., Alwahaibi N., Mohamed J., The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos University Medical Journal 2012 12 1 556 569 2-s2.0-84857082515
13. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
14. Rains J. L., Jain S. K., Oxidative stress, insulin signaling, and diabetes. Free Radical Biology and Medicine 2011 50 5 567 575 2-s2.0-79551470306 10.1016/j.freeradbiomed.2010.12.006
15. Gao S. H., Gong Y. B., Ni Q., Luo Z. G., Zhao J. X., Gao Y. B., Yang X. H., Feng X. Z., Clinical study on treatment of type 2 diabetes from aspects of liver, spleen and kidney. Zhong Hua Zhong Yi Yao Za Zhi 2009 24 8 1007 1010
16. Anwer T., Sharma M., Khan G., Iqbal M., Ali M. S., Alam M. S., Safhi M. M., Gupta N., Rhus coriaria ameliorates insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM) rats. Acta Poloniae Pharmaceutica 2012 70 5 861 867
17. Srinivasan K., Ramarao P., Animal models in type 2 diabetes research: an overview. Indian Journal of Medical Research 2007 125 3 451 472 2-s2.0-34249279490 (Pubitemid 46805458)
18. Chatzigeorgiou A., Halapas A., Kalafatakis K., Kamper E. F., The use of animal models in the study of diabetes mellitus. In Vivo 2009 23 2 245 258 2-s2.0-64549104842
19. Zhang Z., Xue H. L., Liu Y., Wang W. J., Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats. World Journal of Gastroenterology 2011 17 8 987 995 2-s2.0-79955928910 10.3748/wjg.v17.i8.987
20. Dhar A., Dhar I., Jiang B., Desai K. M., Wu L., Chronic methylglyoxal infusion by minipump causes pancreatic β -cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes 2011 60 3 899 908 2-s2.0-79952403213 10.2337/db10-0627
21. Heo M., Kim E., Effects of endurance training on lipid metabolism and glycosylated hemoglobin levels in streptozotocin-induced type 2 diabetic rats on a high-fat diet. Journal of Physical Therapy Science 2013 25 8 989 992 10.1589/jpts.25.989
22. Smith U., Pioglitazone: mechanism of action. International Journal of Clinical Practice, Supplement 2001 121 13 18 2-s2.0-0034804726 (Pubitemid 32916691)
23. Dong H., Wang N., Zhao L., Lu F., Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine 2012 2012 12 2-s2.0-84868692016 10.1155/2012/591654 591654
24. Chang C. L. T., Lin Y., Bartolome A. P., Chen Y., Chiu S., Yang W., Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evidence-Based Complementary and Alternative Medicine 2013 2013 33 2-s2.0-84877311655 10.1155/2013/378657 378657
25. Li Z., Geng Y. N., Jiang J. D., Kong W. J., Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evidence-Based Complementary and Alternative Medicine 2014 2014 12 289264 10.1155/2014/289264
26. Zhang L., Yang J., Chen X. Q., Zan K., Wen X. D., Chen H., Wang Q., Lai M. X., Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. Journal of Ethnopharmacology 2010 132 2 518 524 2-s2.0-78049406435 10.1016/j.jep.2010.08. 053
27. Li G. Q., Kam A., Wong K. H., Zhou X., Omar E. A., Alqahtani A., Li K. M., Razmovski-Naumovski V., Chan K., Herbal medicines for the management of diabetes. Advances in Experimental Medicine and Biology 2012 771 396 413 2-s2.0-84874536619
28. Abolfathi A. A., Mohajeri D., Rezaie A., Nazeri M., Protective effects of green tea extract against hepatic tissue injury in streptozotocin-induced diabetic rats. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 2-s2.0-84858198745 10.1155/2012/740671 740671
29. Henriksen E. J., Diamond-Stanic M. K., Marchionne E. M., Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radical Biology and Medicine 2011 51 5 993 999 2-s2.0-80051669138 10.1016/j. freeradbiomed.2010.12.005
30. Vardi N., Parlakpinar H., Cetin A., Erdogan A., Ozturk I. C., Protective effect of β -carotene on methotrexate-induced oxidative liver damage. Toxicologic Pathology 2010 38 4 592 597 2-s2.0-77953672605 10.1177/ 0192623310367806
31. Fukai T., Ushio-Fukai M., Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants and Redox Signaling 2011 15 6 1583 1606 2-s2.0-79961193678 10.1089/ars.2011.3999
32. Kasznicki J., Kosmalski M., Sliwinska A., Mrowicka M., Stanczyk M., Majsterek I., Drzewoski J., Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Molecular Biology Reports 2012 39 9 8669 8678 2-s2.0-84865110431 10.1007/s11033-012-1722-9
33. Hamed S., Brenner B., Roguin A., Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovascular Research 2011 91 1 9 15 2-s2.0-79958833427 10.1093/cvr/cvq412
34. Diamond-Stanic M. K., Marchionne E. M., Teachey M. K., Durazo D. E., Kim J. S., Henriksen E. J., Critical role of the transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress. Biochemical and Biophysical Research Communications 2011 405 3 439 444 2-s2.0-79951575665 10.1016/j.bbrc.2011.01.049
35. Samarghandian S., Borji A., Delkhosh M. B., Samini F., Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmaceutical Sciences 2013 16 2 352 362